Breaking News

MilliporeSigma Shares Best Practices and Insights on Bio-Mfg. Topics

To discuss Convergence of IT, OT and Processing Technologies, Capacity Demands, and Facility Intensification

Related CONTENT

04.02.19

Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technologies Today and Tomorrow
April 3, 10:30 a.m. – 11:00 a.m., stage 5, booth #2477
Joshua Hays, senior innovation manager, Software & Automation

Meeting Bioprocessing Manufacturing Capacity Demands – discussing solutions for efficient, cost-effective biologic drug manufacturing – Panel Discussion
April 3, 11:00 a.m. – noon, innovation stage, #1281
Panelist: Mike Felo, Integrated Solutions, BioContinuum™ Platform for Next-Generation Processing

Facility Intensification and Cost Reduction Opportunities using an Integrated Buffer Delivery Platform
April 3, 2:15 p.m. – 3:00 p.m., stage 3, booth #1877
Mike Felo, Integrated Solutions, BioContinuum™ Platform for Next- Generation Processing

Related Searches

Suggested For You

Catalent Biologics to Present at INTERPHEX

Catalent Biologics to Present at INTERPHEX

PCI Bolsters Supply Chain Leadership

PCI Bolsters Supply Chain Leadership

Biopharma Contract Fill-and-Finish Market Trends

Biopharma Contract Fill-and-Finish Market Trends

Sartorius, Novasep Enter Bioprocessing Alliance

Sartorius, Novasep Enter Bioprocessing Alliance

WCG Acquires First Clinical Research

WCG Acquires First Clinical Research

Nasal Drug Delivery

Nasal Drug Delivery

FDA & Data Integrity

FDA & Data Integrity

Rentschler Biopharma Appoints Mfg. VP

Rentschler Biopharma Appoints Mfg. VP

Eurofins Lancaster Laboratories Professional Scientific Services

Eurofins Lancaster Laboratories Professional Scientific Services

Digital Manufacturing a Top Priority for Life Sciences

Digital Manufacturing a Top Priority for Life Sciences

Cobra Biologics, Pall, Cell and Gene Therapy in Continuous Mfg. Tie-up

Cobra Biologics, Pall, Cell and Gene Therapy in Continuous Mfg. Tie-up

Streamlining Drug Development:

Streamlining Drug Development:

Dedicated to Excellence

Dedicated to Excellence

Current market developments and their multifaceted impacts

Current market developments and their multifaceted impacts

Related Breaking News

Breaking News | Industry News | Promotions & Moves

TCG Lifesciences Names Chief Scientific Officer

Dr. Chris Senanayake is a globally recognized pharma industry innovator and opinion leader in the field of chemical research and development.
01.17.20
Breaking News | Cold Chain Management | Facilities | Industry News | Packaging & Tracking

Packaging Technology Group to Open Kentucky Facility

Accelerates growth with new site in Louisville, slated to open April 2020.
01.17.20
Breaking News | Industry News | Promotions & Moves

Nanoform Appoints Head of US Sales

Sally Langa to lead biz dev efforts across the U.S.
01.17.20
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

WuXi Biologics Buys Bayer Site in Germany

First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.
01.17.20
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves

Catalent Strengthens Biologics Business

Makes key senior appointments.
01.17.20
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

BridgeBio Pharma, Catalent Enter Gene Therapy Alliance

Deal is designed to accelerate BridgeBio’s gene therapy programs; dedicated suite will support clinical and commercial supply needs.
01.17.20
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News

Civica Rx, Thermo Fisher Ink Long-term Deal

To develop and manufacture drugs with a history of drug shortages.
01.17.20
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Just - Evotec, OncoResponse Enter Antibody Alliance

Will leverage J.DESIGN to provide OncoResponse with services to accelerate OR2805 into the clinic
01.16.20
Breaking News | Drug Development | Industry News

Sun Pharma, Rockwell Medical Enter Licensing and Supply Pact

Sun Pharma will be the exclusive development and commercialization partner for Rockwell's Triferic
01.16.20
Breaking News | Drug Development | Industry News

Azymus Therapeutics Launches to Address Challenging Diseases

Advances 10-years of nano-therapeutic research supported by its flagship AZ Platform
01.16.20
Breaking News

CNS Pharmaceuticals Announced Contract with International GMP Manufacturer for Berubicin

Production will ensure availability through the completion of its Phase II Clinical Trials.
01.15.20
Breaking News

My Green Lab Announced Collaboration with AstraZeneca

Global Green Lab Certification program leads the way in the pharmaceutical industry.
01.15.20
Breaking News

ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement

For Lava’s Novel Bispecific Molecule.
01.15.20
Breaking News

ANI Launches Paliperidone Extended-Release Tablets

An atypical antipsychotic agent for treatment of schizophrenia.
01.15.20
Breaking News

ASC Therapeutics and Vigene Announced Long-Term Partnership

Partnership for gene therapy development and manufacturing.
01.15.20